Here are 10 conversation starters and 5 must-ask questions to help you maximize your networking at SCOPE Summit 2025.
10 Conversation Starters
-
What’s the biggest takeaway you’ve had from past SCOPE Summits? This reflective question helps break the ice and jump start a conversation about how your organizations can work together.
-
What trends are you seeing in clinical trial innovation that you're most intrigued about? This gives you insight into what emerging technologies, methodologies, or shifts in the industry landscape your peers are interested in.
-
What are your thoughts on the future of personalized medicine and its impact on clinical trial design? Asking about this topic can reveal how organizations are addressing challenges like smaller patient populations and biomarker development. It’s also a chance to discuss the potential for personalized approaches to improve patient outcomes and drug approval rates.
-
I noticed that your company recently partnered with [Partner's Name] on [Project/Initiative]. What were the key factors that led to this collaboration? Recognizing a company’s recent partnership demonstrates preparation and interest in their strategic priorities. It can open a dialogue about decision-making processes, mutual goals, and how the partnership is benefiting clinical trials. This also creates an opportunity to discuss future collaborations.
-
Given the increasing importance of patient-centric trial designs, how is your organization adapting to prioritize patient engagement? This question can reveal how organizations are implementing tools and strategies to increase patient recruitment, retention, and satisfaction. It also helps uncover how companies are responding to the growing demand for diversity and representation in trials.
-
What are the biggest challenges you've encountered with implementing risk-based quality management? By sharing challenges and solutions, you can gain insights into common hurdles such as data standardization and technology adoption. This discussion also offers a chance to learn about innovative approaches to maintaining trial quality.
-
In light of recent advancements, how is your organization approaching the integration of digital health technologies into your clinical trials? Learning about an organization’s approach to these technologies can uncover insights into their benefits and limitations. It also provides an opportunity to discuss the impact on patient adherence and trial efficiency.
-
What was the biggest lesson you learned from recent collaborations with CROs or sponsors? By discussing past experiences, you can gain insights into best practices, challenges, and key takeaways. This conversation also sets the stage for exploring potential future partnerships.
-
If you could solve one big challenge in clinical trials tomorrow, what would it be? This big-picture question gives colleagues a chance to share their vision and priorities for the coming year. Their discussion can provide valuable context for identifying potential collaboration opportunities or aligning solutions to each other's needs.
-
What strategies are you using to improve diversity in clinical trial recruitment, and what results have you seen so far? This question allows for discussions about strategies like community outreach, partnerships with advocacy groups, and the use of decentralized trial models to reach underrepresented groups. It also opens the door to sharing lessons learned and success stories, which can inspire innovative approaches to inclusive trial recruitment.
5 Must-Ask Questions
-
How is your organization integrating artificial intelligence (AI) and machine learning into clinical trial processes? Asking this question can reveal how organizations are leveraging these technologies for tasks like patient recruitment, trial monitoring, and data analysis. It also opens the door to discuss the challenges and opportunities in adopting cutting-edge tools.
-
What strategies are you employing to enhance data interoperability and transparency in clinical trials? Discussing interoperability strategies can provide insights into how organizations are improving trial efficiency and compliance with regulatory requirements. Transparency is also critical to building trust with patients, regulators, and collaborators, making this a timely topic.
-
In what ways are you addressing decentralized and hybrid trial models? Decentralized and hybrid trial models have emerged as powerful ways to improve patient participation and reduce costs, but they come with unique logistical challenges. Learning how organizations are implementing these models can help identify best practices and potential pitfalls. This question also enables a deeper dive into how technology, regulatory adjustments, and community-based approaches are shaping the future of trials.
-
How are current regulatory trends influencing your clinical development strategies? The regulatory landscape is constantly evolving, influencing how organizations plan and conduct clinical trials. Understanding how companies navigate these changes can reveal strategies to stay compliant while maintaining efficiency and innovation. It’s also a great way to share insights into adapting to global regulatory frameworks.
-
What measures are you taking to build supply chain resilience in response to recent global challenges? Supply chain disruptions have highlighted vulnerabilities in clinical trial operations. Discussing how organizations are fortifying their supply chains can uncover strategies to ensure consistent access to materials, products, and data. This question is especially relevant given the industry's focus on adaptability in a rapidly changing world.